Physician profile
Han Soo Kim
NPI 1124078282
$10,197.99
in general payments reported to CMS, 2019-2025
8 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $297 · 2021: $7,784 · 2023: $1,491 · 2024: $373 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,755 · Food and Beverage: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,754.64 |
| Food and Beverage | $363.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,061.11 | 2020-2021 | |
| Cornerstone Medical Associates, INC. | $889.71 | 2023 | |
| Arthrex, INC. | $601.16 | 2023 | |
| Alphatec Spine, INC | $565.08 | 2024-2025 | Other - Miscellaneous |
| Pacira Pharmaceuticals Incorporated | $28.12 | 2024 | Exparel |
| Integra Lifesciences Corporation | $19.61 | 2024 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Baudax Bio INC. | $19.17 | 2020 | |
| Smith+Nephew, INC. | $14.03 | 2025 | Small Cannulated Screws, Ascension, Hat-Trick |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Han Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.